These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 33129040)
1. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium. Rubio-San-Simón A; André N; Cefalo MG; Aerts I; Castañeda A; Benezech S; Makin G; van Eijkelenburg N; Nysom K; Marshall L; Gambart M; Hladun R; Rossig C; Bergamaschi L; Fagioli F; Carpenter B; Ducassou S; Owens C; Øra I; Ribelles AJ; De Wilde B; Guerra-García P; Strullu M; Rizzari C; Ek T; Hettmer S; Gerber NU; Rawlings C; Diezi M; Palmu S; Ruggiero A; Verdú J; de Rojas T; Vassal G; Geoerger B; Moreno L; Bautista F Eur J Cancer; 2020 Dec; 141():82-91. PubMed ID: 33129040 [TBL] [Abstract][Full Text] [Related]
2. Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP). Rubio-San-Simón A; Verdú-Amorós J; Hladun R; Juan-Ribelles A; Molero M; Guerra-García P; Pérez-Martínez A; Castañeda A; Cañete A; de Rojas T; Moreno L; Bautista F Clin Transl Oncol; 2021 Jan; 23(1):183-189. PubMed ID: 32472454 [TBL] [Abstract][Full Text] [Related]
3. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium. Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085 [TBL] [Abstract][Full Text] [Related]
4. Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic. Nasser S; Fotopoulou C; Gültekin M; Dimitrova D; Bilir E; Inci G; Morice P; Mirza MR; Martin AG; Berek J; Sehouli J; Arch Gynecol Obstet; 2024 Jul; 310(1):577-586. PubMed ID: 38836928 [TBL] [Abstract][Full Text] [Related]
5. Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study. Graetz D; Agulnik A; Ranadive R; Vedaraju Y; Chen Y; Chantada G; Metzger ML; Mukkada S; Force LM; Friedrich P; Lam C; Sniderman E; Bhakta N; Hessissen L; Dalvi R; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Moreira DC Lancet Child Adolesc Health; 2021 May; 5(5):332-340. PubMed ID: 33675698 [TBL] [Abstract][Full Text] [Related]
6. Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer. Bautista F; Verdú-Amorós J; Geoerger B; Rubio-San-Simón A; Paoletti X; Zwaan CM; Casanova M; Marshall LV; Carceller F; Doz F; Lecinse C; Vassal G; Pearson ADJ; Kearns P; Moreno L; J Clin Oncol; 2024 Jul; 42(21):2516-2526. PubMed ID: 38743911 [TBL] [Abstract][Full Text] [Related]
7. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey. Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491 [TBL] [Abstract][Full Text] [Related]
8. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology. Onesti CE; Tagliamento M; Curigliano G; Harbeck N; Bartsch R; Wildiers H; Tjan-Heijnen V; Martin M; Rottey S; Generali D; Campone M; Cristofanilli M; Pusztai L; Peeters M; Berchem G; Cortes J; Ruhstaller T; Ciruelos E; Rugo HS; Jerusalem G JCO Glob Oncol; 2021 Feb; 7():162-172. PubMed ID: 33529077 [TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. Chazan G; Franchini F; Alexander M; Banerjee S; Mileshkin L; Blinman P; Zielinski R; Karikios D; Pavlakis N; Peters S; Lordick F; Ball D; Wright G; I Jzerman M; Solomon B ESMO Open; 2020 Dec; 5(6):e001090. PubMed ID: 33262203 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671 [TBL] [Abstract][Full Text] [Related]
11. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. Salmanton-García J; Wipfler P; Valle-Simón P; Merakou C; Kopsidas I; Bethe U; Steinbach A; Spivak O; Součková L; Mendonça MA; Koniordou M; Hellemans M; Frías-Iniesta J; Davis RJ; Barta I; Azzini AM; Askling HH; Argyropoulos CD; Álvarez-Barco E; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Flisiak R; Husa P; Jancoriene L; Koscalova A; Launay O; Lundgren J; Mallon P; Marques L; Nauclér P; Ochando J; Pana ZD; Tacconelli E; Tóth K; Trelle S; van Damme P; Zaoutis TE; Zeitlinger M; Albus K; Stewart FA; Hofstraat SHI; Bruijning-Verhagen P; Cornely OA; Vaccine; 2023 Jun; 41(26):3915-3922. PubMed ID: 37210309 [TBL] [Abstract][Full Text] [Related]
12. Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium. Bautista F; Moreno L; Marshall L; Pearson ADJ; Geoerger B; Paoletti X Eur J Cancer; 2017 Nov; 86():275-284. PubMed ID: 29055843 [TBL] [Abstract][Full Text] [Related]
13. Responses of paediatric emergency departments to the first wave of the COVID-19 pandemic in Europe: a cross-sectional survey study. Rose K; Bressan S; Honeyford K; Bognar Z; Buonsenso D; Da Dalt L; De T; Farrugia R; Parri N; Oostenbrink R; Maconochie I; Moll HA; Roland D; Titomanlio L; Nijman R; ; BMJ Paediatr Open; 2021 Dec; 5(1):. PubMed ID: 35413003 [TBL] [Abstract][Full Text] [Related]
14. [An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown]. Ghrieb Z; Allaoua S; Huang J; Langner N; François F; Maréchal C; Jebali M; Lebbé C; Chellah A; Bergeron A; Kiladjian JJ; Daltro De Oliveira R; Soret-Dulphy J; Benajiba L Therapie; 2021; 76(4):347-358. PubMed ID: 33640116 [TBL] [Abstract][Full Text] [Related]
15. [Early clinical trials in paediatric oncology in Spain: a nationwide perspective]. Bautista F; Gallego S; Cañete A; Mora J; Díaz de Heredia C; Cruz O; Fernández JM; Rives S; Berlanga P; Hladun R; Juan Ribelles A; Madero L; Ramírez M; Fernández Delgado R; Pérez-Martínez A; Mata C; Llort A; Martín Broto J; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L; ; An Pediatr (Barc); 2017 Sep; 87(3):155-163. PubMed ID: 28279690 [TBL] [Abstract][Full Text] [Related]
17. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea. Jeon J; Kim H; Yu KS J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
20. A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region. Abati E; Nelva Stellio L; Manini A; Moroni F; Azzalini L; Vilca LM Ann Med; 2022 Dec; 54(1):2326-2339. PubMed ID: 36001504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]